logo ECCN european conference of clinical neuroimaging 2025 Madrid Spain

MADRID, Spain 24-26 MARCH, 2025

ABOUT THE EVENT

2025 Annual Meeting: ECCN MADRID

ECCN 2025 Madrid Spain

The 13th European Conference on Clinical Neuroimaging (ECCN, March 24th-26th, 2025) will again bring together physicians and researchers from all brain imaging modalities (from PET to SPECT and MRI) and will also provide a window into other innovative biomarkers, new technologies and emerging areas of clinical neuroimaging.
We look forward to seeing you in Madrid to discuss clinical neuroimaging and science.

 

Javier Arbizu,

Professor and Director of the Department of Nuclear Medicine, University of Navarra and Clinica Universidad de Navarra, Pamplona and MADRID, Spain.

Franck Semah,

Professor, Head of Imaging Department, University Hospital of LILLE, France

SCIENTIFIC COMMITTEE

PRELIMINARY PROGRAM

REGISTRATION

165min

WELCOME COFFEE

60min

WELCOME

  • Prof. Dr. Christoph Josten, Medical Director and Spokesman of the Management Board, Leipzig University Medical Center
  • Prof. Dr. Ingo Bechmann, Dean of the Faculty of Medicine, University of Leipzig

45min

LECTURE SESSION 1

Brain and Beyond – Total-Body PET Chairs: Nelleke Tolboom (Netherlands) - Valentin Riedl (Germany)

  • Ivo Rausch (Austria): The Basics of Total-Body PET
  • Björn Falkenburger (Germany): The Gut–Brain Axis in Parkinson’s Disease
  • Frank Bengel (Germany): The Brain and the Heart: Imaging of Organ Crosstalk

90min

SATELLITE SYMPOSIUM 1

Positrigo

Chairs: Donatienne Van Weehaeghe/Bernhard Sattler: Dedicated Scanners - Bringing Brain PET to the People
  1. Silvia Morbelli: Potential of Dedicated Brain PET in Movement Disorders
  2. Henryk Barthel: Potential of Dedicated Brain PET in Dementia Disorders

45min

COFFEE BREAK

30min

SPECIAL LECTURE

Imaging Brain Tumours

Clemens Seidel (Germany): Imaging of Brain Tumours - What the Radiotherapists Want to Know.

15min

ORAL COMMUNICATION 1

Imaging Brain Tumours

Chairs: Diego Cecchin (Italy) - Clemens Seidel (Germany)
  • Giulia Vallini: A novel imaging biomarker in gliomas: metabolic connectivity mapping from dynamic [18F]FDG PET data
  • Michele Mureddu: A semi-automatic pipeline for extracting static and dynamic parameters from 18F-DOPA PET in high- and low-grade pediatric gliomas
  • Nathalie Testart Dardel: Diagnostic accuracy of FET-PET in brain metastasis

45min

SATELLITE SYMPOSIUM 2

GE HealthCare

Chairs: Antoine Verger (France) - Silvia Morbelli (Italy)
Nicolai Franzmeier, Ludwig Maximilian University of Munich (Germany):
  • The Utility of amyloid-PET in the era of disease modifying treatments in Alzheimer's disease

45min

ORAL COMMUNICATION 2

FDG PET Imaging in Dementia

Chairs: Eric Guedj (France) - Juergen Dukart (Germany)
  • Antonia Bose: Quantifying the effect of varying levels of systemic blood sugar on cerebral energy metabolism
  • Valentin Riedl: The energetic costs of signaling as a proxy of cognition in health and disease
  • Antoine Rogeau: Unsupervised anomaly detection of brain [18F]-FDG PET in Alzheimer's disease and frontotemporal dementia
  • Florent Hives: Cerebral metabolism in patients with typical vs atypical frontotemporal dementia and alzheimer’s disease
  • Michal Pudis: Evaluation of Brain Metabolic Pattern in Niemann-Pick Type C Disease

75min

COFFEE BREAK

30min

SATELLITE SYMPOSIUM 3

Life Molecular Imaging

Chairs: Tatjana Traub-Weidinger (Austria) - Henryk Barthel (Germany)

45min

ORAL COMMUNICATION 3

PET Imaging in Dementia - Other Tracers than FDG

Chairs: Swen Hesse (Germany) - Matthias Schroeter (Germany)
  • Liang Gong (China): Sex-specific entorhinal cortex functional connectivity in cognitively normal older adults with amyloid-β pathology
  • Cecilia Boccalini (Switzerland): Early-phase [18F]Flortaucipir tau-PET as a measure of neurodegeneration: a comparison with [18F]FDG-PET and early-phase amyloid-PET
  • Ricardo Espinosa (Switzerland): Brain connectivity of early-phase amyloid imaging in Alzheimer's disease
  • Norman Koglin (Germany: Experiences from clinical research and routine use with neuraceq amyloid pet - a decade of post-authorisation insights.
  • Eóin Molloy (Germany): Establishment of a deeply phenotyped cohort to determine factors of successful cognitive ageing
  • Michal Pudis (Spain) : Evaluation of the Utility of PET/MRI with Amyloid in the Diagnosis of Cerebral Amyloid Angiopathy

90mn

LUNCH

75min

LECTURE SESSION 2

Imaging in Psychiatry
Chairs: Julia Sacher (Germany)- Koen van Laere (Belgium)

  • Gerhard Gründer (Germany): Clinical Imaging in Psychiatry
  • Gitte M. Knudsen (Denmark): Dynamic Coupling of Brain Neuronal and Neurotransmitter Systems
  • Rupert Lanzenberger (Austria): New targets, new approaches, new biomarkers in neuroimaging: QUO VADIS?

90min

COFFEE BREAK

30min

ORAL COMMUNICATION 4

Imaging Other Brain States

Chairs: Maria Strauß (Germany) - Jan Booij (Netherlands)
  • Denise Visser (The Netherlands): Imaging the post-COVID brain 2 years after infection using [18F]DPA-714 PET and MRI: is it all between the ears?
  • Maja Badendick (Germany): Central α4β2*nicotinic receptor availability (nAChR) availability is significantly influenced by leptin in human obesity (OB)
  • Melanie Storch (Germany): Hypothalamic volume in pedophilia with or without child sexual offense
  • Sebastien Heyer (France): Brain 18F-FDG PET: an efficient tool at the initial diagnosis of non-lesional late-onset epilepsy

60min

AWARDS

15min

SATELLITE SYMPOSIUM 4

GE HealthCare

Chairs: Ralph Buchert (Germany) - Franck Semah (France)
Diego Cecchin, University of Padova (Italy): A StarGuide european multicentric study on DAT imaging: early and late acquisitions  

45min

NETWORKING EVENT

LECTURE SESSION 3

The ATN Concept in AD
Chairs: Donatienne Van Weehaeghe (Belgium), Igor Yakushev (Germany)

  • Emrah Düzel (Germany): Super Aging – A Great Model to Improve Understanding of AD
  • Nik Weißkopf (Germany): High-Field MRI – Improved Insights Into the Brain
  • Markus Otto (Germany): Fluid Biomarkers for ATN Staging in AD

90min

COFFEE BREAK

30min

SPECIAL LECTURE

Imaging Parkinsonian Syndromes:

  • My Jonasson: 11C-PE2I-PET for Differential Diagnosis of Parkinsonism

30 mn

ORAL COMMUNICATION 5

Imaging Parkinsonian Syndromes:

Chairs: Solveig Tiepolt (Germany), Anne Maass (Germany)
  • Anthime FLAUS: CT-guided spatial normalisation of [123]I-FP-CIT SPECT images versus SPECT-guided normalisation to discriminate abnormal from normal putaminal uptake
  • Franziska Albrecht: Predicting the brain age of people with Parkinson’s disease utilizing minimally processed magnetic resonance images
  • Elon Wallert: Accuracy of AI-driven susceptibility map-weighted MRI analyses to differentiate neurodegenerative from non-neurodegenerative parkinsonism

60min

LUNCH

75min

RAPID FIRE SESSION

Chairs : Marianne Patt (Germany) Swen Hesse (Germany)

  • Sara Cabras (Italy): Investigating the role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in Amyotrophic Lateral Sclerosis.
  • Liang Gong (China): Personalized Brain Network Mechanisms and Prediction of Chronic Insomnia Disorder with Comorbid Depression.
  • Hamza Khan (Belgium): Predicting Disability Progression in People with Multiple Sclerosis: Combining Volumetric and Radiomics Features from T2-Weighted FLAIR MR Images.
  • Marie Stroske (Germany): Hypothalamus and Third Ventricle Volume of Patients with Affective Disorders.
  • Peter Schoenknecht (Germany): Mammillary body and hypothalamic volumes in mood disorders.
  • Zixiao Yin (Germany, China): Generalized sleep decoding with basal ganglia signals in multiple movement disorders.
  • Frederik Buchholz (Germany): Subgenual ACC gray matter volumes in mood disorders.
  • Laurent Sheybani (United-Kingdom): Wake slow waves impact epileptic discharges and cognition in focal human epilepsy.
  • Uta Claußnitzer (Germany): Development of an Interactive Segmentation Algorithm of the Hippocampus Using 7T T1 Weighted Mr-Images in Humans.
  • Kerrin Pine (Germany): Ultrahigh field quantitative MRI for repeatable characterization of the subcortex.
  • Julia Wolff (Germany): A Semi-Automated Algorithm for Hypothalamus Volumetry in 3-Tesla Magnetic Resonance Images.
  • Benedikt Kürzinger (Germany): Automated structural analysis of the amygdala in affective disorders using 7T MRI in vivo.
  • Rajendra Badgaiyan (United States): Use of Dynamic Neurotransmitter Imaging technique to study neuropathology of psychiatric and neurological conditions.
  • Dimitra Kiakou (Czech Republic): Functional MRI-based classification of Deep Brain Stimulation states in Parkinson’s disease.

140min

CONCLUSION

25min

END OF THE CONFERENCE

CALL FOR ABSTRACTS

ABSTRACTS

Abstracts can be submitted from October 1 to December 16, 2024

REGISTRATION FEES

Physician / Scientist

Early-Bird rates: 390€

(Before Feb 19, 2025)

 

Regular price: 500€

(Feb 19 – March 20, 2025)

 

On site: 550€

(24-26 March)

Industry participant

Early-Bird rates: 590€

(Before Feb 19, 2025)

 

Regular price: 690€

(Feb 19 – March 20, 2025)

 

On site: 740€

(24-26 March)

Student / Resident

Early-Bird rates: 190€

(Before Feb 19, 2025)

 

Regular price: 250€

(Feb 19 – March 20, 2025)

 

On site: 300€

(24-26 March)

SPONSORS 2024

Thanks to our 2024 sponsors for their support

KEY DATES

Copyright 2023 ECCN All rights reserved | LEGAL | Policy Privacy